Table 2. The clinical and serological manifestations of patients with SLE.

		All	Male (n = 15)	Female (n = 60)	P value*
		N (% of group)	N (% of group)	N (% of group)
Malar rash	+	49 (76.6)	11 (91.7)	38 (73.1)	0.27
	−	15 (23.4)	1 (8.3)	14 (26.9)
Arthritis	+	39 (60.0)	6 (50.0)	33 (62.3)	0.52
	−	26 (40.0)	6 (50.0)	20 (37.7)
Serositis	+	4 (6.3)	1 (10.0)	3 (5.7)	0.51
	−	59 (93.7)	9 (90.0)	50 (94.3)
Thrombocytopenia	+	19 (27.5)	3 (23.1)	16 (28.6)	1.00
	−	50 (72.5)	10 (76.9)	40 (71.4)
Proteinuria	+	47 (65.3)	13 (92.9)	34 (58.6)	0.026
	−	25 (34.7)	1 (7.1)	24 (41.4)
Anti-dsDNA	+	55 (93.2)	11 (91.7)	44 (93.6)	1.00
	−	4 (6.8)	1 (8.3)	3 (6.4)

^*Fisher’s exact p value.